{"protocolSection":{"identificationModule":{"nctId":"NCT01790997","orgStudyIdInfo":{"id":"DLBS1033-UST-001.11"},"organization":{"fullName":"Dexa Medica Group","class":"INDUSTRY"},"briefTitle":"Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke","officialTitle":"The Role of DLBS1033 in Evaluating Bleeding Profile and Clinical Outcome in Patients With Acute Ischemic Stroke: Comparison With Aspirin and Clopidogrel"},"statusModule":{"statusVerifiedDate":"2014-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-05"},"primaryCompletionDateStruct":{"date":"2013-11","type":"ACTUAL"},"completionDateStruct":{"date":"2013-12","type":"ACTUAL"},"studyFirstSubmitDate":"2013-02-12","studyFirstSubmitQcDate":"2013-02-12","studyFirstPostDateStruct":{"date":"2013-02-13","type":"ESTIMATED"},"lastUpdateSubmitDate":"2014-06-03","lastUpdatePostDateStruct":{"date":"2014-06-04","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Dexa Medica Group","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"This is a 3-arm, prospective, randomized, double-blind, and controlled clinical study, with 3 months of treatment to evaluate efficacy of DLBS1033 in bleeding profile and clinical outcome in patients with acute ischemic stroke compared with aspirin and clopidogrel, as active controls.","detailedDescription":"There will be 3 groups of treatment; each group will consist of 43 subjects with the treatment regimens :\n\n* Treatment I : 1 tablet of DLBS1033 490 mg thrice daily, after meal\n* Treatment II : 1 tablet of aspirin 80 mg once daily, after meal\n* Treatment III : 1 tablet of clopidogrel 75 mg once daily, after meal\n\nBleeding profile (by measuring INR value, PT, and aPTT) and clinical outcome (by measuring Gadjah Mada Stroke Scale and Barthel Index) to evaluate the efficacy of the investigational drug will be performed at baseline and end of study (Month 3rd). General condition of the subjects will be followed-up every month over three months of study medication.\n\nPhysiotherapy will be provided to the subjects by the assigned Physiotherapist."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"],"keywords":["DLBS1033","Lumbrokinase","Acute ischemic stroke","Bleeding profile","Clinical outcome","Aspirin","Clopidogrel"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":126,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Treatment I","type":"EXPERIMENTAL","description":"1 tablet of DLBS1033 490 mg thrice daily, after meal","interventionNames":["Drug: DLBS1033"]},{"label":"Treatment II","type":"ACTIVE_COMPARATOR","description":"1 tablet of aspirin 80 mg once daily, after meal","interventionNames":["Drug: Aspirin"]},{"label":"Treatment III","type":"ACTIVE_COMPARATOR","description":"1 tablet of clopidogrel 75 mg once daily, after meal","interventionNames":["Drug: Clopidogrel"]}],"interventions":[{"type":"DRUG","name":"DLBS1033","description":"1 tablet of DLBS1033 490 mg thrice daily, after meal","armGroupLabels":["Treatment I"]},{"type":"DRUG","name":"Aspirin","description":"1 tablet of aspirin 80 mg once daily, after meal","armGroupLabels":["Treatment II"]},{"type":"DRUG","name":"Clopidogrel","description":"1 tablet of clopidogrel 75 mg once daily, after meal","armGroupLabels":["Treatment III"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in INR value","description":"Change in INR (international normalized ratio) value from baseline to end of study (Month 3rd)","timeFrame":"3 Months"}],"secondaryOutcomes":[{"measure":"Change in PT","description":"Change in PT (prothrombin time) from baseline to end of study (Month 3rd)","timeFrame":"3 Months"},{"measure":"Change in aPTT","description":"Change in aPTT (activated-partial thromboplastin time) from baseline to end of study (Month 3rd)","timeFrame":"3 Months"},{"measure":"Change in Gadjah Mada Stroke Scale","description":"Change in Gadjah Mada Stroke Scale from baseline to end of study (Month 3rd)","timeFrame":"3 Months"},{"measure":"Change in Barthel Index","description":"Change in Barthel Index from baseline to end of study (Month 3rd)","timeFrame":"3 Months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female subjects aged 20-80 years old\n* Having non-bleeding stroke in CT scan examination\n* Having stroke attack onset â‰¤ 96 hours\n* Living in 100 km from RSUP Dr Sardjito Jogjakarta\n\nExclusion Criteria:\n\n* Having recurrence stroke\n* Having Transient Ischemic Attack (TIA)\n* Have been regularly taking anti-aggregation agent\n* Having intracerebral and subarachnoid bleeding stroke\n* Subjects and their family do not know when the stroke symptoms appeared\n* History of haemostasis disorder\n* History of or will have surgery within 6 months prior to screening","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Ismail Setyopranoto, dr., SpS(K)","affiliation":"Stroke Unit, Department of Neurology, Faculty of Medicine, Gadjah Mada University, dr. Sardjito Hospital, Jogjakarta, Indonesia","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Stroke Unit, Department of Neurology, Faculty of Medicine, Gadjah Mada University, dr. Sardjito Hospital","city":"Yogyakarta","state":"Jogjakarta","zip":"55281","country":"Indonesia","geoPoint":{"lat":-7.80139,"lon":110.36472}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M9246","name":"Hemorrhage","relevance":"LOW"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001241","term":"Aspirin"},{"id":"D000077144","term":"Clopidogrel"}],"ancestors":[{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000058921","term":"Purinergic P2Y Receptor Antagonists"},{"id":"D000058919","term":"Purinergic P2 Receptor Antagonists"},{"id":"D000058914","term":"Purinergic Antagonists"},{"id":"D000058905","term":"Purinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","asFound":"Knee","relevance":"HIGH"},{"id":"M1669","name":"Clopidogrel","asFound":"Results","relevance":"HIGH"},{"id":"M3907","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M3908","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M20476","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M20294","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M18899","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M28866","name":"Antipyretics","relevance":"LOW"},{"id":"M28984","name":"Purinergic P2Y Receptor Antagonists","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}